Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives - An extended structure-activity relationship study

European Journal of Medicinal Chemistry

Volumn 43, Issue 3, 2008, Pages 633-656

  Mahboobi, Siavosh ^a   Eichhorn, Emerich ^a   Winkler, Matthias ^a   Sellmer, Andreas ^a   Möllmann, Ute ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Antibacterial compounds; Indole derivatives; Resistance of Staphylococcus aureus; SAR study

Indexed keywords

3 BROMO 4 (1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE DERIVATIVE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; INDOLE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 40049094628     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.05.009     Document Type: Article

References (29)

1. F. Baquero J. Antimicrob. Chemother. 39 1997 1 6
2. F.C. Tenover J.W. Biddle M.V. Lancaster Emerg. Infec. Dis. 7 2001 327 332
3. M. Marcelo Medicina 62 2002 30 35
4. M. Sancelme S. Fabre M. Prudhomme J. Antibiot. 47 1994 792 798
5. S. Mahboobi E. Eichhorn A. Popp A. Sellmer S. Elz U. Möllmann Eur. J. Med. Chem. 41 2006 176 191
6. A.B. Smith M. Visnick Tetrahedron Lett. 26 1985 3757 3760
7. A.B. Smith M. Visnick J.N. Haseltine P.A. Spengler Tetrahedron Lett. 42 1986 2957 2969
8. U. Vasconcelos E. Dalmoline A.A. Merlo Org. Lett. 7 2004 1027 1030
9. B.F. Bowden R.W. Read E. Ritchie W.C. Taylor Aust. J. Chem. 28 1975 65
10. W. Guba W. Neidhart M. Nettekoven Bioorg. Med. Chem. Lett. 15 2005 1599 1603
11. M.J. Jeong J.H. Park C. Changjin Y. Jil Org. Lett. 8 2006 2221 2224
12. C.P. Miller M.D. Collini B.D. Tran H.A. Harris Y.P. Kharode J.T. Marzolf R.A. Moran R.A. Henderson R.H. Bender R.J. Unwalla L.M. Greenberger J.P. Yardley M.A. Abou-Gharbia C.R. Lyttle B.S. Komm J. Med. Chem. 44 2001 1654 1657
13. Scientific Exchange Inc., USA.
14. M. Murase K. Watanabe T. Kurihara S. Tobinaga Chem. Pharm. Bull. 46 1998 889 892
15. W. Witte C. Cuny C. Braulke D. Heuck Epidemiol. Infect. 113 1994 67 73
16. W. Witte M. Kresken C. Braulke C. Cuny Clin. Microbiol. Infect. 3 1997 414 422
17. FEMS Microbiol. Lett. 125 1995 165
18. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing, Seventeenth Informational Supplement. vol. 27, Clinical and Laboratory Standards Institute, PA, USA, 2007.
19. L. Heinisch S. Wittmann T. Stoiber A. Berg D. Ankel-Fuchs U. Möllmann J. Med. Chem. 14 2002 3032 3040
20. N. Dechamps R. Flammang P. Gerbaux P.C. Nam M.T. Nguyen J. Am. Soc. Mass Spectrom. 17 2006 807 814
21. G. Cavill N.A. Gibson J. Soc. Chem. Ind. 66 1947 274
22. S. Schnatterer, M. Maier, F. Lochhaas, W. Knauf, K. Seeger. in PCT Int. Appl. (F. Bayer CropScience S.A.), 2006.
23. J.H. Musser, A.J. Molinari, D. Mobilio, (U. American Home Products Corp.), U.S.A., 1993.
24. T. Ando T. Yamanouchi T. Yamashita K. Ikeda A. Kawano F. Tsuchiya F. Sediko Jpn. Kokai Tokyo Koho 1992
25. B.H. Han D.H. Shin S.Y. Cho Tetrahedron Lett. 26 1985 6233 6234
26. J.Q. Liu Q.Z. Zhang J.Z. Zhang Chin. Chem. Lett. 15 2004 1423 1426
27. E. von Angerer J. Prekajak J. Strohmeier J. Med. Chem. 27 1984 1439 1447
28. S.K. Anandan J.S. Ward R.D. Brokx M.R. Bray D.V. Patel X.X. Xiao Bioorg. Med. Chem. Lett. 15 2005 1969 1972
29. J.P. Collman Y.L. Yan J. Lei P.H. Dinolfo Org. Lett. 8 2006 923 926